SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 39.08% in the sales to Rs. 4464.71 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 3210.12 millions during the year-ago period.The company almost doubled its revenue to Rs. 512.25 millions  from Rs. 248.15 millions in the quarter ended June 2026.Operating Profit saw a handsome growth to 1179.19 millions from 851.30 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4464.71 3210.12 39.08 4464.71 3210.12 39.08 14053.81 12995.89 8.14
Other Income 37.87 52.55 -27.94 37.87 52.55 -27.94 150.08 176.82 -15.12
PBIDT 1179.19 851.30 38.52 1179.19 851.30 38.52 2840.01 3869.57 -26.61
Interest 305.17 270.31 12.90 305.17 270.31 12.90 1205.76 1616.50 -25.41
PBDT 874.02 580.99 50.44 874.02 580.99 50.44 1580.05 1130.57 39.76
Depreciation 361.77 332.84 8.69 361.77 332.84 8.69 1367.95 1345.12 1.70
PBT 512.25 248.15 106.43 512.25 248.15 106.43 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -414.55 0.00
PAT 512.25 248.15 106.43 512.25 248.15 106.43 212.10 200.00 6.05
Equity 114.64 114.46 0.16 114.64 114.46 0.16 114.62 114.43 0.17
PBIDTM(%) 26.41 26.52 -0.41 26.41 26.52 -0.41 20.21 29.78 -32.13

Onesource Specialty Share Price

1689.60 36.20 (2.19%)
27-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1973.50
Dr. Reddys Labs. 1150.90
Cipla 1409.85
Lupin 2409.90
Zydus Lifesciences 1108.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: